Newsfeeds - Spark Newswire

4 minute read

FDA
News

Adamis Pharmaceuticals Provides Update On Clinical Study Assessing Tempol For The Treatment Of COVID-19; Says

Today, 2:33 PM

Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19 SAN DIEGO, March 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today

ADMP

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 2:33 PM

Gainers

ADMP

2 minute read

FDA
News

Adamis Pharmaceuticals Provides Enrollment Update Of Subjects In Phase 2/3 Study Of Tempol For Treatment of COVID-19

By Benzinga Newsdesk

Today, 2:33 PM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced the enrollment and dosing of more than 100 subjects in the Company's ongoing Phase 2/3 study of Tempol for the treatment of COVID-19. The

ADMP

1 minute read

Adamis Pharmaceuticals Shares Move Higher; Traders Circulate Seeking Alpha Blog Post From Contributor Biologics’ Blog Titled ‘Adamis Pharmaceuticals: Market Continues To Overlook TEMPOL’s Potential To Be A Leading COVID-19 Therapeutic’

By Benzinga Newsdesk

Today, 2:33 PM

https://seekingalpha.com/article/4480577-adamis-pharmaceuticals-tempol-potential-leading-covid-19-therapeutic

ADMP

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:33 PM

Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.

AACG

3 minute read

28 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 2:33 PM

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year.

ADMP

5 minute read

56 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:33 PM

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).

ADMP

1 minute read

News

Adamis Pharmaceuticals Says Regains Compliance With NASDAQ Continued Listing Requirements

By Benzinga Newsdesk

Today, 2:33 PM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced

ADMP

2 minute read

Earnings Scheduled For November 22, 2021

By Benzinga Insights

Today, 2:33 PM

Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million.

3 minute read

The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week

By Shanthi Rexaline

Today, 2:33 PM

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting season and ahead of the holiday week.

AADI